Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXELIXIS, INC. Director's Dealing 2020

May 16, 2020

30561_dirs_2020-05-15_befa9688-3979-4e30-8381-6cec5e163d5f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2020-05-15

Reporting Person: SCANGOS GEORGE A (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-05-15 Common Stock M 30000 $4.58 Acquired 768031 Direct
2020-05-15 Common Stock M 21686 $5.82 Acquired 789717 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-05-15 Option (right to buy) $4.58 M 30000 Disposed 2020-05-22 Common Stock (30000.0) Direct
2020-05-15 Option (right to buy) $5.82 M 21686 Disposed 2020-12-05 Common Stock (21686.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 8963 Indirect
Common Stock 8963 Indirect
Common Stock 5669 Indirect

Footnotes

F1: Shares held by George A. Scangos and Leslie S. Wilson, as Trustees of the Jennifer Scangos Trust.

F2: Shares held by George A. Scangos and Leslie S. Wilson, as Trustees of the Katherine Scangos Trust.

F3: Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of May 14, 2020.

F4: The option, representing the right to purchase a total of 30,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 23, 2013.

F5: The option, representing the right to purchase a total of 21,686 shares of Exelixis, Inc. common stock, became fully exercisable on December 6, 2013.